300 million single cell atlas now accessible to the scientific community comprised of Vevo's Tahoe-100M, mapping 60,000 drug-patient interactions, and Arc's AI-curated scBaseCamp 200 million cell ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Vevo Therapeutics, a biotechnology company using its Mosaic technology and next-generation AI to uncover better drugs for more patients, ...
Vevo has announced plans to headquarter its European business at the Lighthouse building in London’s Kings Cross. The grade II listed premises will provide 16,292 sq ft of space across four floors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback